Previous close | 91.20 |
Open | 90.03 |
Bid | 78.38 x 100 |
Ask | 82.80 x 100 |
Day's range | 81.10 - 86.78 |
52-week range | 76.02 - 99.56 |
Volume | |
Avg. volume | 1,412,556 |
Market cap | 15.445B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 93.55 |
EPS (TTM) | 0.87 |
Earnings date | 24 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 110.10 |
Q1 2024 Biomarin Pharmaceutical Inc Earnings Call
Explore key financial achievements and strategic directions from Biomarin's latest earnings call.
The headline numbers for BioMarin (BMRN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.